JNCE
Price:
$1.88
Market Cap:
$98.95M
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; JTX -1484 for myeloid; and JTX-1811, an anti-CCR8 monoclonal antibody designed to selectively deplete intra-tumoral T regulatory cells in the tumor microenvironment. Jounce Therapeutics...[Read more]
Industry
Biotechnology
IPO Date
2017-01-26
Stock Exchange
NASDAQ
Ticker
JNCE
According to Jounce Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -41597260.00. This represents a change of -145.54% compared to the average of 91.34M of the last 4 quarters.
The mean historical Enterprise Value of Jounce Therapeutics, Inc. over the last ten years is 242.81M. The current -41597260.00 Enterprise Value has changed -1813.14% with respect to the historical average. Over the past ten years (40 quarters), JNCE's Enterprise Value was at its highest in in the March 2018 quarter at 600.79M. The Enterprise Value was at its lowest in in the December 2022 quarter at -83191640.00.
Average
242.81M
Median
274.34M
Minimum
-83191640.00
Maximum
475.45M
Discovering the peaks and valleys of Jounce Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 329.58%
Maximum Annual Enterprise Value = 475.45M
Minimum Annual Increase = -124.83%
Minimum Annual Enterprise Value = -83191640.00
Year | Enterprise Value | Change |
---|---|---|
2022 | -83191640.00 | -124.83% |
2021 | 335.08M | 185.47% |
2020 | 117.38M | -55.86% |
2019 | 265.94M | 329.58% |
2018 | 61.91M | -82.79% |
2017 | 359.70M | -24.34% |
2016 | 475.45M | 73.30% |
2015 | 274.34M | -27.56% |
The current Enterprise Value of Jounce Therapeutics, Inc. (JNCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
123.09M
5-year avg
139.42M
10-year avg
242.81M
Jounce Therapeutics, Inc.’s Enterprise Value is less than Assembly Biosciences, Inc. (90.35M), less than Spero Therapeutics, Inc. (12.49M), greater than Achilles Therapeutics plc (-61068820.00), less than Instil Bio, Inc. (171.51M), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (62.24M), less than NextCure, Inc. (25.04M), less than Nuvation Bio Inc. (947.94M),
Company | Enterprise Value | Market cap |
---|---|---|
90.35M | $107.81M | |
12.49M | $71.07M | |
-61068820.00 | $29.58M | |
171.51M | $92.68M | |
-6333315.00 | $8.20M | |
62.24M | $93.74M | |
25.04M | $39.73M | |
947.94M | $692.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jounce Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jounce Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Jounce Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Jounce Therapeutics, Inc. (JNCE)?
What is the 3-year average Enterprise Value for Jounce Therapeutics, Inc. (JNCE)?
What is the 5-year average Enterprise Value for Jounce Therapeutics, Inc. (JNCE)?
How does the current Enterprise Value for Jounce Therapeutics, Inc. (JNCE) compare to its historical average?